• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎膜炎破裂后一氧化氮生成短暂缺陷及对缺氧性呼吸衰竭早产儿吸入性一氧化氮的反应性。

Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure.

机构信息

Department of Pediatrics, University of Oulu, Oulu, Finland.

出版信息

J Pediatr. 2012 Sep;161(3):397-403.e1. doi: 10.1016/j.jpeds.2012.03.008. Epub 2012 May 1.

DOI:10.1016/j.jpeds.2012.03.008
PMID:22554621
Abstract

OBJECTIVE

To study antenatal risk factors and inflammatory responses during hypoxic respiratory failure (HRF) in infants of very low gestational age (VLGA, ≤32.0 weeks).

STUDY DESIGN

Of a cohort of 765 VLGA infants, 144 required mechanical ventilation. Airway specimens from these patients were prospectively studied. Infants who developed HRF (oxygenation index >25) with echocardiographic diagnosis of pulmonary hypertension were treated with inhaled nitric oxide (iNO). Three gestation comparison groups were formed on the basis of specific antenatal complications: prolonged preterm rupture of membranes (PPROM), spontaneous preterm birth, and preeclampsia. Chest radiographs were studied and airway specimens were analyzed for concentrations of tumor necrosis factor-α, interleukin (IL)-6, IL-8, IL-10, IL-12p70, IL-1β, and nitrite + nitrate over 4 days.

RESULTS

Seventeen (2.2% of all VLGA infants) developed HRF. In all 17 cases, PPROM complicated the antenatal course; these infants responded to iNO, regardless of infection or PPROM. The chest radiographs of HRF and non-HRF PPROM infants were similar. Airway proinflammatory cytokines and nitrite + nitrate levels were low in infants with HRF, but they increased during iNO treatment and remained elevated after discontinuation of iNO. Each of the 3 comparison groups had different and characteristic patterns of airway cytokines and nitrite + nitrate levels.

CONCLUSIONS

Seven percent of VLGA infants with preterm rupture of membranes and 15% of those with PPROM developed HRF, characterized by pulmonary hypertension that acutely responds to iNO. These infants may have a transient deficiency in the inflammatory response, including a defect in nitric oxide generation in airspaces.

摘要

目的

研究极低出生体重儿(VLGA,≤32.0 周)发生低氧性呼吸衰竭(HRF)的产前危险因素和炎症反应。

研究设计

在 765 名 VLGA 婴儿中,有 144 名需要机械通气。对这些患者的气道标本进行了前瞻性研究。患有 HRF(氧合指数>25)并伴有超声心动图诊断为肺动脉高压的婴儿接受了吸入一氧化氮(iNO)治疗。根据特定的产前并发症形成了 3 个孕龄比较组:延长的早产胎膜早破(PPROM)、自发性早产和子痫前期。研究了胸部 X 光片,并分析了气道标本中肿瘤坏死因子-α、白细胞介素(IL)-6、IL-8、IL-10、IL-12p70、IL-1β和亚硝酸盐+硝酸盐在 4 天内的浓度。

结果

17 名(所有 VLGA 婴儿的 2.2%)发生 HRF。在所有 17 例 HRF 病例中,PPROM 使产前过程复杂化;这些婴儿对 iNO 有反应,无论是否存在感染或 PPROM。HRF 和非 HRF PPROM 婴儿的胸部 X 光片相似。HRF 婴儿的气道促炎细胞因子和亚硝酸盐+硝酸盐水平较低,但在 iNO 治疗期间增加,并在 iNO 停用后仍保持升高。3 个比较组中的每一组都有不同的和特征性的气道细胞因子和亚硝酸盐+硝酸盐水平模式。

结论

7%的有早产胎膜早破的 VLGA 婴儿和 15%的有 PPROM 的婴儿发生 HRF,其特征是肺动脉高压对 iNO 急性反应。这些婴儿可能存在短暂的炎症反应缺陷,包括气腔中一氧化氮生成缺陷。

相似文献

1
Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure.胎膜炎破裂后一氧化氮生成短暂缺陷及对缺氧性呼吸衰竭早产儿吸入性一氧化氮的反应性。
J Pediatr. 2012 Sep;161(3):397-403.e1. doi: 10.1016/j.jpeds.2012.03.008. Epub 2012 May 1.
2
Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?早产儿早期使用吸入一氧化氮:是否有采用选择性方法的理论依据?
Am J Perinatol. 2017 Apr;34(5):428-440. doi: 10.1055/s-0036-1592346. Epub 2016 Sep 14.
3
Early functional echocardiogram and inhaled nitric oxide: usefulness in managing neonates born following extreme preterm premature rupture of membranes (PPROM).早期功能性超声心动图与吸入一氧化氮:对胎膜早破极早早产儿出生后管理的作用
J Paediatr Child Health. 2011 Jun;47(6):340-5. doi: 10.1111/j.1440-1754.2010.01982.x. Epub 2011 Feb 11.
4
Early Hypoxic Respiratory Failure in Extreme Prematurity: Mortality and Neurodevelopmental Outcomes.极早早产儿早期低氧性呼吸衰竭:死亡率和神经发育结局。
Pediatrics. 2020 Oct;146(4). doi: 10.1542/peds.2019-3318. Epub 2020 Sep 17.
5
The safety and efficacy of nitric oxide therapy in premature infants.一氧化氮疗法用于早产儿的安全性和有效性。
J Pediatr. 2005 Mar;146(3):318-23. doi: 10.1016/j.jpeds.2004.10.019.
6
Characteristics of pulmonary hypertension in preterm neonates.早产儿肺动脉高压的特征
J Perinatol. 2007 Apr;27(4):214-9. doi: 10.1038/sj.jp.7211673. Epub 2007 Mar 1.
7
Association between immediate oxygenation response and survival in preterm infants receiving rescue inhaled nitric oxide therapy for hypoxemia from pulmonary hypertension: A systematic review and meta-analysis.接受吸入性一氧化氮抢救治疗肺高压性低氧血症的早产儿中即刻氧合反应与生存的关系:系统评价和荟萃分析。
Early Hum Dev. 2023 Sep;184:105841. doi: 10.1016/j.earlhumdev.2023.105841. Epub 2023 Aug 2.
8
Use of inhaled nitric oxide in preterm infants.吸入一氧化氮在早产儿中的应用。
Pediatrics. 2014 Jan;133(1):164-70. doi: 10.1542/peds.2013-3444. Epub 2013 Dec 30.
9
Inhaled nitric oxide for respiratory failure in preterm infants.吸入一氧化氮治疗早产儿呼吸衰竭。
Neonatology. 2012;102(4):251-3. doi: 10.1159/000338552. Epub 2012 Aug 15.
10
Inhaled nitric oxide in newborns with severe hypoxic respiratory failure.重度缺氧性呼吸衰竭新生儿吸入一氧化氮治疗
J Med Assoc Thai. 2007 Feb;90(2):266-71.

引用本文的文献

1
International treatment outcomes of neonates on extracorporeal membrane oxygenation (ECMO) with persistent pulmonary hypertension of the newborn (PPHN): a systematic review.国际体外膜肺氧合(ECMO)治疗新生儿持续肺动脉高压(PPHN)的结局:系统评价。
J Cardiothorac Surg. 2024 Aug 24;19(1):493. doi: 10.1186/s13019-024-03011-3.
2
The current clinical landscape of neonatal respiratory failure in Jiangsu Province of China: patient demographics, NICU treatment interventions, and patient outcomes.中国江苏省新生儿呼吸衰竭的临床现状:患者人口统计学资料、NICU 治疗干预措施和患者结局。
BMC Pediatr. 2024 Apr 25;24(1):272. doi: 10.1186/s12887-024-04741-y.
3
Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future.
支气管肺发育不良婴儿肺动脉高压的药物治疗:过去、现在与未来
Pharmaceuticals (Basel). 2023 Mar 28;16(4):503. doi: 10.3390/ph16040503.
4
Pulmonary Vascular Phenotypes of Prematurity: The Path to Precision Medicine.早产儿肺血管表型:迈向精准医学之路。
J Pediatr. 2023 Aug;259:113444. doi: 10.1016/j.jpeds.2023.113444. Epub 2023 Apr 25.
5
Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide.ABO 血型与吸入一氧化氮治疗新生儿持续性肺动脉高压婴儿的治疗反应和疗效的相关性。
BMC Pregnancy Childbirth. 2023 Apr 22;23(1):276. doi: 10.1186/s12884-023-05558-w.
6
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update.欧洲呼吸窘迫综合征管理共识指南:2022 年更新版。
Neonatology. 2023;120(1):3-23. doi: 10.1159/000528914. Epub 2023 Feb 15.
7
Endothelial dysfunction in preterm infants: The hidden legacy of uteroplacental pathologies.早产儿的内皮功能障碍:子宫胎盘病变的潜在遗留问题。
Front Pediatr. 2022 Nov 4;10:1041919. doi: 10.3389/fped.2022.1041919. eCollection 2022.
8
Pulmonary hypertension in the newborn- etiology and pathogenesis.新生儿肺动脉高压——病因与发病机制。
Semin Fetal Neonatal Med. 2022 Aug;27(4):101381. doi: 10.1016/j.siny.2022.101381. Epub 2022 Aug 7.
9
Management Practices During Perinatal Respiratory Transition of Very Premature Infants.极早产儿围产期呼吸过渡期间的管理实践
Front Pediatr. 2022 May 10;10:862038. doi: 10.3389/fped.2022.862038. eCollection 2022.
10
Group 3 Pulmonary Hypertension: From Bench to Bedside.第 3 组肺动脉高压:从基础到临床。
Circ Res. 2022 Apr 29;130(9):1404-1422. doi: 10.1161/CIRCRESAHA.121.319970. Epub 2022 Apr 28.